BioSpace News Archive

Browse BioSpace’s published news and press releases by year, month, and day.
256 Results
Year
Month
Day
  • Company name: Er-Kim Ilac Presentative: Cem Zorlular, CEO AnGes, Inc., a Japanese biopharmaceutical company focused on gene-based medicines and Er-Kim, a leading Turkish specialty pharma company; today announce an exclusive licensing and distribution agreement for Er-Kim to commercialize AnGes’ gene therapy product Collategene® for Critical Limb Ischemia patients in Turkey. Under the terms of the agreement,
  • Eargo, Inc. (“Eargo”), a medical device company dedicated to improving the quality of life of people with hearing loss, announced today the pricing of its initial public offering of 7,851,852 shares of its common stock at a public offering price of $18.00 per share. In connection with the offering, Eargo has granted the underwriters a 30-day option to purchase up to an additional 1,177,777 shares of common stock at the initial public offering
  • Tarsus Pharmaceuticals, Inc. announced the pricing of its initial public offering of 5,500,000 shares of common stock at a public offering price of $16.00 per share, for gross proceeds of $88.0 million, before underwriting discounts, commissions, and offering expenses payable by Tarsus.
  • IntelGenx Technologies Corp. announces the closing of an offering by way of private placement to certain investors in the United States of U.S.$1.2 million principal amount of 8% convertible notes due October 15, 2024.
  • NeuroX, an online Neurology and Psychology clinic, and Stratus, the leader in home EEG testing, today announced that Stratus will partner with NeuroX to provide in-home video electroencephalogram (EEG) diagnostics
  • Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance, announced the pricing of its upsized initial public offering of 10,000,000 shares of common stock at a public offering price of $19.00 per share.